NCT06892249

Brief Summary

Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2) Exclusion criteria (1) Has received dialysis or are expected to start dialysis within the next 3 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jun 2025Dec 2027

First Submitted

Initial submission to the registry

March 12, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 4, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

2.6 years

First QC Date

March 12, 2025

Last Update Submit

September 30, 2026

Conditions

CKDLow Protein Dietary IntakeMalnutrition (Calorie)

Outcome Measures

Primary Outcomes (1)

  • Change in body weight from Baseline to end of treatment at Week 4 (Week 4 - Baseline)

    4 weeks

Study Arms (1)

Renalive® LP

EXPERIMENTAL
Dietary Supplement: Renalive® LP,

Interventions

Renalive® LP,DIETARY_SUPPLEMENT

flavour

Renalive® LP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2)

You may not qualify if:

  • (1) Has received dialysis or are expected to start dialysis within the next 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kaosiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan

RECRUITING

Taipei TzuChi Hospital

New Taipei City, Taiwan

RECRUITING

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 24, 2025

Study Start

June 4, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

October 1, 2026

Record last verified: 2026-09

Locations

TW(2)